Random Thoughts ....
I have read every post that has
Random Thoughts ....
I have read every post that has been made since Friday's Proxy was posted and have a few thoughts that I would like to share. The range of emotions by those reading the proxy ranged from Chicken LIttle andthe sky is falling, to having total confidence in the items up for vote to those who are taking a neutral position until more info is available. For what it is worth, here is my 2 cents on the subject.
As CEO of a company, that individual has the accountablility to create a vision and make decisions that will provide shareholder value and return a profit to those investors that have put their $$$ in his hands. In order to be successful, he must create a PLAN. Although it is HIS plan, he does not live in a vacum and relies on people to advise him on the best course of action in the future. I admit that he has had some bumps in the implementation of the PLAN but he has taken steps, many steps to bring into the comopany the best talent available to carry out the vision.
I just read his blog and I feel personally feel he is being very open to what he feels is needed to move the company in the future. Each shareholder has the right to vote on the proposals. Either you like what you read and will vote to support the proposals or you don't like what you have read and vote to reject, sell your shares and have a great life with your other investments. Make the best decision that you feel is right for you and your family.
The next question is what will happen to the share price tomorrow. Will it tank, move upward or stay in the .11 range? I wish I had waited to buy the 259k two weeks ago but I am not sorry that I added when I did. I have not sold a single share of my holdings in AMBS and do not plan on selling anytime soon.
I invested in the science, the dream that people suffering from multiple illnesses can have a better life in the future. I have continued to buy shares because of the leadership running this company. My confidence level gets stronger with the PLAN Gerald has for the future and after reading his sharing of information in the latest blog it explains more about what is up for a vote. I am willing to stay the course and remain a loyal shareholder while Gerald continues implementing his PLAN!!
One more thing -- I applaud him for providing the blog before tomorrow's open. It may have helped reduce those needing "suicide watch".
Good luck in your AMBS shareholder strategy whatever that may be!
Poker Guy
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Top 5 Most Recently Viewed Articles
Adam Lowe's Notable Stock Transactions Revealed Adam Lowe, the Chief Product & Innovation Officer at CompoSecure, Inc. (NASDAQ: CMPO), has recently stirred up some buzz following his stock sales, which amounted to over $490,000. According to recent regulatory filings, on a pivotal day, Lowe sold 40,658 shares of CompoSecure's Class A Common Stock, netting him $490,335...
Continue Reading
Extendicare's Positive Financial Performance in Q4 2024 Extendicare Inc. (TSX: EXE) has released its results for the last quarter of 2024, showcasing significant growth and a successful year overall. The company, known for its commitment to quality care for seniors across Canada, reported a remarkable increase in adjusted EBITDA, a key indicator of financial performance,...
Continue Reading
Embracing Exclusive Escapes in Ubud A couple of days ago, The Kayon Resort decided to stir the pot in Ubud's luxury accommodation landscape by rolling out two swanky villa categories: the Premier Pool Villa and the Royal Jacuzzi Pool Villa. No pandering here, just straight-up elegance mingling with nature. Why Ubud's Going Gaga Over Privacy People are craving privacy and...
Continue Reading
The Outdoor Backpacks Market Growth Story The Outdoor Backpacks Market is experiencing remarkable growth, expected to increase by USD 997.1 million between 2025 and 2029. This growth reflects a projected CAGR of approximately 5.4%, driven primarily by rising interest in hiking among millennials. Today's outdoor enthusiasts are not just looking for gear; they desire...
Continue Reading
Nuveen stirred the pot back in 2024 with a fresh drop on their closed-end funds (CEFs), rolling out distribution notices that laid bare the guts of their quarterly payouts. Yeah, those notices were packed with juicy details about where investors' cash was coming from—like net investment income and capital gains—but they also signaled some unsettling shifts lurking...
Continue Reading